Fiducial marker implantation in prostate radiation therapy: Complication rates and technique

Cancer/Radiotherapie

Volumn 18, Issue 8, 2014, Pages 736-739

  Fawaz, Z S ^a,b   Yassa, M ^a   Nguyen, D H ^a   Vavassis, P ^a  

^a MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Complications; Fiducial markers; Gold seeds; Prostate cancer; Radiation therapy; Radiotherapy; Technique

Indexed keywords

CIPROFLOXACIN; FLEET ENEMA;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; FIDUCIAL MARKER; HUMAN; IMAGE GUIDED RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PROSTATE CANCER; PROSTATE VOLUME; RADIATION ONCOLOGIST; TRANSRECTAL ULTRASONOGRAPHY; URINARY TRACT INFECTION; URINE CULTURE; COMPUTER ASSISTED RADIOTHERAPY; PROCEDURES; PROSTATIC NEOPLASMS; PROSTHESIS IMPLANTATION; RECTUM; RETROSPECTIVE STUDY;

FIDUCIAL MARKERS; HUMANS; MALE; PROSTATIC NEOPLASMS; PROSTHESIS IMPLANTATION; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; RECTUM; RETROSPECTIVE STUDIES;

EID: 84918813926     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2014.07.160     Document Type: Article

References (24)

1. Roeske J.C., Forman J.D., Mesina C.F., He T., Pelizzari C.A., Fontenla E., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995, 33:1321-1329.
2. Balter J.M., Sandler H.M., Lam K., Bree R.L., Lichter A.S., ten Haken R.K. Measurement of prostate movement over the course of routine radiotherapy using implanted markers. Int J Radiat Oncol Biol Phys 1995, 31:113-118.
3. Crook J.M., Raymond Y., Salhani D., Yang H., Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol 1995, 37:35-42.
4. Melian E., Mageras G.S., Fuks Z., Leibel S.A., Niehaus A., Lorant H., et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys 1997, 38:73-81.
5. Litzenberg D., Dawson L.A., Sandler H., Sanda M.G., McShan D.L., Ten Haken R.K., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 2002, 52:699-703.
6. Nederveen A.J., Dehnad H., van der Heide U.A., van Moorselaar R.J., Hofman P., Lagendijk J.J., et al. Comparison of megavoltage position verification for prostate irradiation based on bony anatomy and implanted fiducials. Radiother Oncol 2003, 68:81-88.
7. Malone S., Crook J.M., Kendal W.S., Szanto J. Respiratory-induced prostate motion: quantification and characterization. Int J Radiat Oncol Biol Phys 2000, 48:105-109.
8. Dawson L.A., Litzenberg D.W., Brock K.K., Sanda M., Sullivan M., Sandler H.M., et al. A comparison of ventilatory prostate movement in four treatment positions. Int J Radiat Oncol Biol Phys 2000, 48:319-323.
9. Wu J., Haycocks T., Alasti H., Ottewell G., Middlemiss N., Abdolell M., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 2001, 61:127-133.
10. Welsh J.S., Berta C., Borzillary S., Sam C., Shickell D., Nobile L., et al. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy. Technol Cancer Res Treat 2004, 3:359-364.
11. Alicikus Z.A., Yamada Y., Zhang Z., Pei X., Hunt M., Kollmeier M., et al. Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 2011, 117:1429-1437.
12. Dehnad H., Nederveen A.J., van der Heide U.A., van Moorselaar R.J., Hofman P., Lagendijk J.J. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 2003, 67:295-302.
13. Chung P.W., Haycocks T., Brown T., Cambridge Z., Kelly V., Alasti H., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 2004, 60:329-334.
14. Shinohara K., Roach M. Technique for implantation of fiducial markers in the prostate. Urology 2008, 71:196-200.
15. Kothary N., Dieterich S., Louie J.D., Chang D.T., Hofmann L.V., Sze D.Y. Percutaneous implantation of fiducial markers for imaging-guided radiation therapy. AJR Am J Roentgenol 2009, 192:1090-1096.
16. Heidenreich A., Aus G., Bolla M., Joniau S., Matveev V.B., Schmid H.P., et al. EAU guidelines on prostate cancer. Eur Urol 2008, 53:68-80.
17. Linden R.A., Weiner P.R., Gomella L.G., Dicker A.P., Suh D.B., Trabulsi E.J., et al. Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology 2009, 73:881-886.
18. Langenhuijsen J.F., van Lin E.N., Kiemeney L.A., van der Vight L.P., McColl G.M., Visser A.G., et al. Ultrasound-guided transrectal implantation of gold markers for prostate localization during external beam radiotherapy: complication rate and risk factors. Int J Radiat Oncol Biol Phys 2007, 69:671-676.
19. Igdem S., Akpinar H., Alço G., Agaçayak F., Turkan S., Okkan S., et al. Implantation of fiducial markers for image guidance in prostate radiotherapy: patient-reported toxicity. Br J Radiol 2009, 82:941-945.
20. Gill S., Li J., Thomas J., Bressel M., Thursky K., Styles C., et al. Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy. Br J Radiol 2012, 85:1011-1017.
21. Poggi M.M., Gant D.A., Sewchand W., Warlick W.B. Marker seed migration in prostate localization. Int J Radiat Oncol Biol Phys 2003, 56:1248-1251.
22. Chowdhury R., Abbas A., Idriz S., Hoy A., Rutherford E.E., Smart J.M. Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. Clin Radiol 2012, 67:e64-e70.
23. Carmignani L., Picozzi S., Bozzini G., Negri E., Ricci C., Gaeta M., et al. Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: a meta-analysis. Transfus Apher Sci 2011, 45:275-280.
24. Raheem O.A., Casey R.G., Galvin D.J., Manecksha R.P., Varadaraj H., McDermott T., et al. Discontinuation of anticoagulant or antiplatelet therapy for transrectal ultrasound-guided prostate biopsies: a single-center experience. Korean J Urol 2012, 53:234-239.